PHARMACIE TOUR DES ROCHES : revenue, balance sheet and financial ratios

PHARMACIE TOUR DES ROCHES is a French company founded 23 years ago, specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé. Based in SAINT-PAUL (97460), this company of category PME shows in 2022 a revenue of 968 k€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-02

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - PHARMACIE TOUR DES ROCHES (SIREN 447606443)
Indicator 2025 2024 2022 2021 2020 2013
Revenue N/C N/C 968 223 € 906 263 € 955 027 € 894 685 €
Net income 18 834 € 23 696 € 85 272 € 59 593 € 100 823 € 107 257 €
EBITDA N/C N/C 90 649 € 96 937 € 115 498 € 121 293 €
Net margin N/C N/C 8.8% 6.6% 10.6% 12.0%

Revenue and income statement

In 2025, PHARMACIE TOUR DES ROCHES generates positive net income of 19 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2013-2025: 107 k€ -> 19 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

18 834 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

The debt ratio (= Financial debt / Equity x 100) stands at 134%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 37%. The balance between equity and debt is satisfactory.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

133.743%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

36.709%

Solvency indicators evolution
PHARMACIE TOUR DES ROCHES

Sector positioning

Debt ratio
133.74 2025
2022
2024
2025
Q1: 13.7
Med: 49.79
Q3: 129.09
Average +17 pts over 3 years

In 2025, the debt ratio of PHARMACIE TOUR DES ROCHES (133.74) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.

Financial autonomy
36.71% 2025
2022
2024
2025
Q1: 33.42%
Med: 53.72%
Q3: 72.08%
Average -16 pts over 3 years

In 2025, the financial autonomy of PHARMACIE TOUR DES ROCHES (36.7%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.

Repayment capacity
3.75 years 2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average

In 2022, the repayment capacity of PHARMACIE TOUR DES ROCHES (3.75) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.

Working capital requirement (WCR) and payment terms

Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
PHARMACIE TOUR DES ROCHES

Positioning of PHARMACIE TOUR DES ROCHES in its sector

Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé

Valuation estimate

Based on 277 transactions of similar company sales in 2025, the value of PHARMACIE TOUR DES ROCHES is estimated at 299 180 € (range 203 025€ - 469 455€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.

Estimated enterprise value 2025
277 transactions
203k€ 299k€ 469k€
299 180 € Range: 203 025€ - 469 455€
NAF 5 année 2025

Valuation method used

Net Income Multiple
18 834 € × 15.9x = 299 180 €
Range: 203 025€ - 469 455€

Only this financial indicator is available for this company.

Valuation evolution

How is this estimate calculated?

This estimate is based on the analysis of 277 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)

Compare PHARMACIE TOUR DES ROCHES with other companies in the same sector:

Voir toutes les statistiques du secteur Commerce de détail de produits pharmaceutiques en magasin spécialisé

Frequently asked questions about PHARMACIE TOUR DES ROCHES

What is the revenue of PHARMACIE TOUR DES ROCHES ?

The revenue of PHARMACIE TOUR DES ROCHES in 2022 is 968 k€.

Is PHARMACIE TOUR DES ROCHES profitable?

Yes, PHARMACIE TOUR DES ROCHES generated a net profit of 19 k€ in 2025.

Where is the headquarters of PHARMACIE TOUR DES ROCHES ?

The headquarters of PHARMACIE TOUR DES ROCHES is located in SAINT-PAUL (97460), in the department La Reunion.

Where to find the tax return of PHARMACIE TOUR DES ROCHES ?

The tax return of PHARMACIE TOUR DES ROCHES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does PHARMACIE TOUR DES ROCHES operate?

PHARMACIE TOUR DES ROCHES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.